Bioray Pharmaceutical Co., Ltd.

This is the first human study of an experimental cancer drug called BR111. The main goal is to find a safe dose and see how the body handles the drug in 166 patients with advanced solid tumors or lymphoma who have run out of standard treatment options. Researchers will also check…

This is the first time a new drug called BRY812 is being tested in people. The main goal is to find a safe dose and see what side effects it causes in adults with advanced cancers that have stopped responding to standard treatments. Researchers will also check if the drug helps s…